Mirae Asset Global Investments Co., Ltd. Amphastar Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,460 shares of AMPH stock, worth $71,014. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,460
Previous 17,920
91.85%
Holding current value
$71,014
Previous $786,000
92.62%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding AMPH
# of Institutions
279Shares Held
34.2MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$289 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$130 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$94.6 Million0.19% of portfolio
-
Td Asset Management Inc1.69MShares$82.3 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$78.9 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.38B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...